Related Experiment Video
Updated: Apr 16, 2026

Inducible and Reversible Dominant-negative DN Protein Inhibition
Published on: January 7, 2019
SLUG is a direct transcriptional repressor of PTEN tumor suppressor
Berna Uygur1, Katrina Abramo, Evgenia Leikina
1Center for Molecular Medicine, Maine Medical Center Research Institute, Scarborough, Maine; Program in Biochemistry and Molecular Biology, University of Maine, Orono, Maine; Section on Membrane Biology, Program of Physical Biology, Eunice Kennedy Shriver National, Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland.
Background:
PTEN/AKT signaling plays a key role in prostate cancer development and maintenance of prostate cancer stem cells. How other oncogenes or tumor suppressors interact with this pathway remain to be elucidated. SLUG is an zinc finger transcription factor of the Snail superfamily, and it promotes cancer metastasis and determines the mammary stem cell state.
Methods:
SLUG was overexpressed in cells by retroviral vector and knockdown of SLUG and PTEN was mediated by shRNAs-expressing lentiviruses. Expression level of SLUG and PTEN was examined by Western blot, RT-PCR, and qPCR analyses. PTEN promoter activity was measured by luciferase reporter assay. ChIP assay was used to measure the binding between SLUG and the PTEN promoter in vivo.
Result:
We showed that overexpression of SLUG decreased expression of PTEN tumor repressor in prostate cancer cell lines 22RV1 and DU145; conversely, knockdown of SLUG expression elevated PTEN expresson at both protein and RNA level in these cells. We demonstrated that SLUG overexpression inhibits PTEN promoter activity through the proximal promoter region in prostate cancer cells. By ChIP assay, we confirmed that SLUG directly binds to the PTEN promoter region covering the E-box sites. We also showed that Slug deficiency leads to an increased expression of PTEN in mouse embryo fibroblasts and prostate tissues. Importantly, we found that overexpression of SLUG increases drug resistance of DU145 prostate cancer cell line and knockdown of SLUG by shRNA sensitizes DU145 cell line to chemotherapeutic drugs. We further demonstrated that PTEN knockdown converts drug sensitivity of DU145 cells expressing SLUG shRNA to anticancer drugs.
Conclusion:
We provide compelling evidence showing that PTEN is a direct functional target of SLUG. Our findings offer new insight in the regulation of the PTEN/AKT pathway and provide a molecular basis for potential targeted therapies of prostate cancer Prostate 75:907-916, 2015. © 2015 Wiley Periodicals, Inc.
Insights
SLUG transcription factor directly targets PTEN, a tumor suppressor, in prostate cancer. This interaction impacts drug resistance and offers new therapeutic targets for prostate cancer treatment.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Stem Cells
Background:
- PTEN/AKT signaling is crucial for prostate cancer development and stem cell maintenance.
- The interaction of oncogenes and tumor suppressors with this pathway requires further investigation.
- SLUG, a transcription factor, is implicated in cancer metastasis and stem cell regulation.
Purpose of the Study:
- To investigate the regulatory relationship between SLUG and PTEN in prostate cancer.
- To elucidate the mechanism by which SLUG influences PTEN expression and activity.
- To explore the therapeutic implications of the SLUG-PTEN interaction in prostate cancer.
Main Methods:
- Overexpression and knockdown of SLUG and PTEN using retroviral and lentiviral vectors.
- Analysis of gene and protein expression via Western blot, RT-PCR, and qPCR.
- Assessment of PTEN promoter activity using luciferase reporter assays and ChIP assays to determine SLUG binding to the PTEN promoter.
Main Results:
- SLUG overexpression decreased PTEN expression in prostate cancer cells, while SLUG knockdown increased it.
- SLUG directly binds to the PTEN promoter, inhibiting its activity.
- SLUG overexpression enhanced drug resistance in prostate cancer cells, whereas SLUG knockdown sensitized them to chemotherapy.
Conclusions:
- PTEN is a direct functional target of SLUG in prostate cancer.
- This study provides novel insights into the regulation of the PTEN/AKT pathway.
- The findings suggest potential therapeutic strategies targeting the SLUG-PTEN axis for prostate cancer treatment.
Related Concept Videos
Abnormal Proliferation
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Loss of Tumor Suppressor Gene Functions
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes
Negative Regulator Molecules

